210 related articles for article (PubMed ID: 16253950)
41. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
Ishitsuka T; Akita H; Harashima H
J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
[TBL] [Abstract][Full Text] [Related]
42. Biodistribution and Tumor Localization of PEG-Modified Dendritic Poly(L-Lysine) Oligonucleotide Complexes.
Kurihara R; Pissuwan D; Mori T; Katayama Y; Niidome T
J Biomater Sci Polym Ed; 2012; 23(18):2369-80. PubMed ID: 22244201
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes.
Song LY; Ahkong QF; Rong Q; Wang Z; Ansell S; Hope MJ; Mui B
Biochim Biophys Acta; 2002 Jan; 1558(1):1-13. PubMed ID: 11750259
[TBL] [Abstract][Full Text] [Related]
44. Modeling cytoplasmic release of encapsulated oligonucleotides from cationic liposomes.
Tamaddon AM; Shirazi FH; Moghimi HR
Int J Pharm; 2007 May; 336(1):174-82. PubMed ID: 17196349
[TBL] [Abstract][Full Text] [Related]
45. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature.
Dandamudi S; Campbell RB
Biochim Biophys Acta; 2007 Mar; 1768(3):427-38. PubMed ID: 17258172
[TBL] [Abstract][Full Text] [Related]
46. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
47. Influence of polymer architecture on the structure of complexes formed by PEG-tertiary amine methacrylate copolymers and phosphorothioate oligonucleotide.
Deshpande MC; Garnett MC; Vamvakaki M; Bailey L; Armes SP; Stolnik S
J Control Release; 2002 May; 81(1-2):185-99. PubMed ID: 11992691
[TBL] [Abstract][Full Text] [Related]
48. Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid.
Chan CL; Majzoub RN; Shirazi RS; Ewert KK; Chen YJ; Liang KS; Safinya CR
Biomaterials; 2012 Jun; 33(19):4928-35. PubMed ID: 22469293
[TBL] [Abstract][Full Text] [Related]
49. Association of liposomes containing a soybean-derived sterylglucoside mixture with rat primary cultured hepatocytes.
Shimizu K; Maitani Y; Takahashi N; Takayama K; Nagai T
Biol Pharm Bull; 1998 Aug; 21(8):818-22. PubMed ID: 9743249
[TBL] [Abstract][Full Text] [Related]
50. Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor.
Tang M; Sakasai S; Onishi H; Kawano K; Hattori Y
J Drug Target; 2023 Jan; 31(1):74-88. PubMed ID: 35864749
[TBL] [Abstract][Full Text] [Related]
51. Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.
Zheng SJ; Zhong S; Zhang JJ; Chen F; Ren H; Deng CL
World J Gastroenterol; 2003 Jun; 9(6):1251-5. PubMed ID: 12800234
[TBL] [Abstract][Full Text] [Related]
52. Electron spin resonance studies of dipalmitoylphosphatidylcholine liposomes containing soybean-derived sterylglucoside.
Muramatsu K; Masumizu T; Maitani Y; Hwang SH; Kohno M; Takayama K; Nagai T
Chem Pharm Bull (Tokyo); 2000 May; 48(5):610-3. PubMed ID: 10823694
[TBL] [Abstract][Full Text] [Related]
53. α, ω-Cholesterol-functionalized low molecular weight polyethylene glycol as a novel modifier of cationic liposomes for gene delivery.
Ma CC; He ZY; Xia S; Ren K; Hui LW; Qin HX; Tang MH; Zeng J; Song XR
Int J Mol Sci; 2014 Nov; 15(11):20339-54. PubMed ID: 25383677
[TBL] [Abstract][Full Text] [Related]
54. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
55. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
Naicker K; Ariatti M; Singh M
Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
[TBL] [Abstract][Full Text] [Related]
56. Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139.
Weecharangsan W; Yu B; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
Anticancer Res; 2010 Jan; 30(1):31-7. PubMed ID: 20150614
[TBL] [Abstract][Full Text] [Related]
57. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
58. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
[TBL] [Abstract][Full Text] [Related]
59. In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles.
Jeong JH; Kim SH; Kim SW; Park TG
J Biomater Sci Polym Ed; 2005; 16(11):1409-19. PubMed ID: 16370241
[TBL] [Abstract][Full Text] [Related]
60. Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes.
Weecharangsan W; Yu B; Zheng Y; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
Mol Pharm; 2009; 6(6):1848-55. PubMed ID: 19725564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
